TPG GP A, LLC, along with James G. Coulter and Jon Winkelried, filed a joint Form 4 on September 15, 2026, reporting the disposal of 18,409,705 shares of LifeStance Health Group, Inc. common stock on September 11, 2026.

Key Highlights

  • Shares disposed: 18,409,705 shares of Common Stock were disposed of (transaction code S) on September 11, 2026.
  • Sale price: The shares were sold at $12.29 per share, according to the filing.
  • Remaining beneficial ownership: Following the transaction, the reporting persons indirectly beneficially own 79,691,702 shares, held through TPG VIII Lynnwood Holdings Aggregation, L.P.
  • Ownership form: All reported beneficial ownership is indirect, through a chain of TPG-affiliated entities.
  • Reporting persons: The joint filing covers TPG GP A, LLC, James G. Coulter, and Jon Winkelried, each identified as a 10% owner in relation to LifeStance Health Group, Inc.
  • Issuer exchange and ticker: LifeStance Health Group, Inc. trades as NASDAQ:LFST.

TPG-Affiliated Entities Reduce Stake in LifeStance Health Group

According to the filing, the three reporting persons - TPG GP A, LLC, James G. Coulter, and Jon Winkelried - jointly reported a sale of 18,409,705 shares of LifeStance Health Group, Inc. common stock on September 11, 2026, at a price of $12.29 per share. The transaction is coded "S," indicating a sale. The filing identifies each reporting person as a 10% owner of the issuer.

The filing explains that Coulter and Winkelried each own entities that control TPG GP A, LLC, which in turn exercises control through a multi-entity chain: TPG Inc., TPG GPCo, LLC, TPG Holdings II-A, LLC, TPG Operating Group II, L.P., TPG Holdings I-A, LLC, TPG Operating Group I, L.P., TPG GenPar VIII Advisors, LLC, TPG GenPar VIII, L.P., and ultimately TPG VIII Lynnwood Holdings Aggregation, L.P. ("TPG VIII Lynnwood"), which directly holds the 79,691,702 shares of Common Stock remaining after the reported transaction.

The filing notes that the reporting persons may be deemed to beneficially own the reported securities "to the extent of the greater of their respective direct or indirect pecuniary interests" in TPG VIII Lynnwood. The filing further states that each of TPG VIII Lynnwood and each reporting person "disclaims beneficial ownership of the securities reported herein, except to the extent of TPG VIII Lynnwood's or such Reporting Person's pecuniary interest therein, if any." The filing also states that it "shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests."

What Was Disclosed

Three affiliated reporting persons jointly disclosed the sale of 18,409,705 shares of LifeStance Health Group common stock at $12.29 per share on September 11, 2026, with 79,691,702 shares remaining indirectly held through TPG VIII Lynnwood following the transaction.